SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cambridge Antibody Technology Group
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: nigel bates10/14/2004 9:49:40 AM
   of 625
 
Humira figures...

The following is a summary of Abbott's third-quarter 2004 sales for selected products. 

     Quarter Ended 9/30/04             Percent         Percent         Percent
     (dollars in millions)             Change  Rest    Change          Change
                                  U.S.   vs.    of       vs.    Global   vs.
                                 Sales  3Q03   World    3Q03     Sales  3Q03
    Pharmaceutical Products Group
    Depakote                     $249    6.4    $13     13.9      $262    6.7
    HUMIRA                       $145   98.7    $82      n/m      $227  189.4
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News